Published in J Thorac Cardiovasc Surg on June 01, 2013
Mitral valve replacement in the presence of massive calcification. J Thorac Cardiovasc Surg (2013) 1.08
Mitral valve replacement in heavily calcified posterior annulus. J Thorac Cardiovasc Surg (2013) 1.05
Reply to the editor. J Thorac Cardiovasc Surg (2013) 0.75
Reply to the editor. J Thorac Cardiovasc Surg (2013) 0.75
Reinforced mitral valve replacement using a xenopericardium collared prosthetic valve for a heavily calcified or disrupted mitral annulus: a simple "Dumpling technique". Surg Today (2016) 0.75
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76
Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA (2011) 2.73
Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42
Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg (2004) 2.37
A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31
Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26
Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation (2005) 2.26
Are all readmissions bad readmissions? N Engl J Med (2010) 2.22
Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20
Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18
Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16
A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13
Editorial: An 'actual' problem: Another issue of apples and oranges. J Heart Valve Dis (2005) 2.11
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09
Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg (2004) 2.03
Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg (2008) 1.99
Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91
Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88
Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg (2006) 1.80
Truncus arteriosus associated with interrupted aortic arch in 50 neonates: a Congenital Heart Surgeons Society study. Ann Thorac Surg (2006) 1.78
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71
What is the preferred therapy for patients with aortic coarctation--the standard gamble and decision analysis versus real results? Cardiol Young (2007) 1.71
Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg (2006) 1.71
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71
A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69
Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg (2003) 1.69
A novel running annuloplasty suture technique for robotically assisted mitral valve repair. J Thorac Cardiovasc Surg (2010) 1.68
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg (2002) 1.66
Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg (2003) 1.65
Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65
Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol (2002) 1.64
Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg (2008) 1.64
Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg (2009) 1.63
Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63
Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation (2006) 1.61
Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation (2002) 1.60
Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg (2006) 1.60
Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59
Does the arterial cannulation site for circulatory arrest influence stroke risk? Ann Thorac Surg (2004) 1.59
Ventilatory dependency after cardiovascular surgery. J Thorac Cardiovasc Surg (2007) 1.58
Robotic posterior mitral leaflet repair: neochordal versus resectional techniques. Ann Thorac Surg (2012) 1.57
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.57
Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? Ann Thorac Surg (2011) 1.56
Does competitive flow reduce internal thoracic artery graft patency? Ann Thorac Surg (2003) 1.56
Major bleeding during HeartMate II support. J Am Coll Cardiol (2013) 1.55
Heart rate recovery and impact of myocardial revascularization on long-term mortality. Circulation (2004) 1.52
Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. Ann Thorac Surg (2005) 1.52
Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation? Ann Thorac Surg (2006) 1.51
Identifying important risk factors for survival in patient with systolic heart failure using random survival forests. Circ Cardiovasc Qual Outcomes (2010) 1.48
Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol (2012) 1.48
Cannulation of the axillary artery with a side graft reduces morbidity. Ann Thorac Surg (2004) 1.48
Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer. J Thorac Oncol (2009) 1.47
Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J (2008) 1.46
Gender differences in outcomes after hospital discharge from coronary artery bypass grafting. Circulation (2006) 1.46
Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg (2003) 1.45
Minimally invasive versus conventional mitral valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg (2009) 1.45
Jugular venous valved conduit (Contegra) matches allograft performance in infant truncus arteriosus repair. Eur J Cardiothorac Surg (2008) 1.45
A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy? J Thorac Cardiovasc Surg (2005) 1.42
Improved outcomes after aortic valve surgery for chronic aortic regurgitation with severe left ventricular dysfunction. J Am Coll Cardiol (2007) 1.41
Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.41
Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation. J Am Coll Cardiol (2013) 1.40
Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann Thorac Surg (2004) 1.40
Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg (2008) 1.39
Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg (2004) 1.39
T2N0M0 esophageal cancer. J Thorac Cardiovasc Surg (2007) 1.38
Spinal cord protective strategies during descending and thoracoabdominal aortic aneurysm repair in the modern era: the role of intrathecal papaverine. J Thorac Cardiovasc Surg (2012) 1.38
Simplified perfusion strategy for removing retroperitoneal tumors with extensive cavoatrial involvement. J Thorac Cardiovasc Surg (2011) 1.38
Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality. J Thorac Cardiovasc Surg (2005) 1.35